Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Several studies have suggested that gut microbiota, including the family Enterobacteriaceae, may play a significant role in the pathogenesis and progression of Non-Alcoholic Fatty Liver Disease (NAFLD).
Specifically, Enterobacteriaceae, along with other bacteria, have been found to be enriched in patients with moderate-severe fibrosis, and their presence has been associated with the severity of liver fibrosis. This suggests a potential link between the composition of intestinal bacteria and the development of Non-Alcoholic Fatty Liver Disease (NAFLD).
It is important to note that Non-Alcoholic Fatty Liver Disease (NAFLD) is closely associated with [obesity](brain://w3iZvE4LekKatLwhqaYcLw/Adiposi…